115 related articles for article (PubMed ID: 37095724)
1. Neoadjuvant therapy does not impact the biliary microbiome in patients with pancreatic cancer.
Behrens S; Sutton TL; Patel R; Schwantes IR; O'Grady J; Johnson A; Grossberg A; Lopez C; Gilbert E; Mayo S; Sheppard BC
J Surg Oncol; 2023 Aug; 128(2):271-279. PubMed ID: 37095724
[TBL] [Abstract][Full Text] [Related]
2. Biliary microbiome in pancreatic cancer: alterations with neoadjuvant therapy.
Goel N; Nadler A; Reddy S; Hoffman JP; Pitt HA
HPB (Oxford); 2019 Dec; 21(12):1753-1760. PubMed ID: 31101398
[TBL] [Abstract][Full Text] [Related]
3. Neoadjuvant chemotherapy for pancreatic cancer and changes in the biliary microbiome.
Nadeem SO; Jajja MR; Maxwell DW; Pouch SM; Sarmiento JM
Am J Surg; 2021 Jul; 222(1):3-7. PubMed ID: 33039150
[TBL] [Abstract][Full Text] [Related]
4. Role of biliary stent and neoadjuvant chemotherapy in the pancreatic tumor microbiome.
Nalluri H; Jensen E; Staley C
BMC Microbiol; 2021 Oct; 21(1):280. PubMed ID: 34656097
[TBL] [Abstract][Full Text] [Related]
5. Neoadjuvant Chemotherapy Enhances Local Postoperative Histopathological Tumour Stage in Borderline Resectable Pancreatic Cancer - A Matched-Pair Analysis.
Timmermann L; Rosumeck N; Klein F; Pratschke J; Pelzer U; Bahra M; Malinka T
Anticancer Res; 2019 Oct; 39(10):5781-5787. PubMed ID: 31570482
[TBL] [Abstract][Full Text] [Related]
6. Impact of Neoadjuvant Therapy in Resected Pancreatic Ductal Adenocarcinoma of the Pancreatic Body or Tail on Surgical and Oncological Outcome: A Propensity-Score Matched Multicenter Study.
Lof S; Korrel M; van Hilst J; Alseidi A; Balzano G; Boggi U; Butturini G; Casadei R; Dokmak S; Edwin B; Falconi M; Keck T; Malleo G; de Pastena M; Tomazic A; Wilmink H; Zerbi A; Besselink MG; Abu Hilal M;
Ann Surg Oncol; 2020 Jun; 27(6):1986-1996. PubMed ID: 31848815
[TBL] [Abstract][Full Text] [Related]
7. Intraoperative Radiotherapy in the Era of Intensive Neoadjuvant Chemotherapy and Chemoradiotherapy for Pancreatic Adenocarcinoma.
Keane FK; Wo JY; Ferrone CR; Clark JW; Blaszkowsky LS; Allen JN; Kwak EL; Ryan DP; Lillemoe KD; Fernandez-Del Castillo C; Hong TS
Am J Clin Oncol; 2018 Jun; 41(6):607-612. PubMed ID: 27740973
[TBL] [Abstract][Full Text] [Related]
8. Impact of Margin Status on Survival in Patients with Pancreatic Ductal Adenocarcinoma Receiving Neoadjuvant Chemotherapy.
Schmocker RK; Delitto D; Wright MJ; Ding D; Cameron JL; Lafaro KJ; Burns WR; Wolfgang CL; Burkhart RA; He J
J Am Coll Surg; 2021 Apr; 232(4):405-413. PubMed ID: 33338577
[TBL] [Abstract][Full Text] [Related]
9. Covered metallic stent placement for biliary drainage could be promising in the coming era of neoadjuvant chemo-radiation therapy for all pancreatic cancer.
Hasegawa S; Kubota K; Yagi S; Kurita Y; Sato T; Hosono K; Matsuyama R; Endo I; Kobayashi N; Nakajima A
J Hepatobiliary Pancreat Sci; 2021 Jul; 28(7):617-624. PubMed ID: 33788414
[TBL] [Abstract][Full Text] [Related]
10. Contemporary analysis of complications associated with biliary stents during neoadjuvant therapy for pancreatic adenocarcinoma.
Kim BJ; Prakash L; Narula N; Davis CH; Kim MP; Aloia TA; Vauthey JN; Lee JE; Katz MH; Tzeng CD
HPB (Oxford); 2019 Jun; 21(6):662-668. PubMed ID: 30522947
[TBL] [Abstract][Full Text] [Related]
11. Radiological and surgical implications of neoadjuvant treatment with FOLFIRINOX for locally advanced and borderline resectable pancreatic cancer.
Ferrone CR; Marchegiani G; Hong TS; Ryan DP; Deshpande V; McDonnell EI; Sabbatino F; Santos DD; Allen JN; Blaszkowsky LS; Clark JW; Faris JE; Goyal L; Kwak EL; Murphy JE; Ting DT; Wo JY; Zhu AX; Warshaw AL; Lillemoe KD; Fernández-del Castillo C
Ann Surg; 2015 Jan; 261(1):12-7. PubMed ID: 25599322
[TBL] [Abstract][Full Text] [Related]
12. Weight loss during neoadjuvant chemotherapy impacts perioperative outcomes in patients undergoing surgery for pancreatic cancer.
Doshi S; Abad J; Wells A; Chawla A
Pancreatology; 2023 Dec; 23(8):1020-1027. PubMed ID: 37926598
[TBL] [Abstract][Full Text] [Related]
13. Intraoperative Bile Culture in Pancreaticoduodenectomy: Teaching Old Dogma New Tricks.
Sutton TL; O'Grady J; Martindale R; Mayo SC; Gilbert EW; Sheppard BC
J Gastrointest Surg; 2022 Jan; 26(1):30-38. PubMed ID: 34704185
[TBL] [Abstract][Full Text] [Related]
14. Clinical Impact of Neoadjuvant Chemotherapy and Chemoradiotherapy in Borderline Resectable Pancreatic Cancer: Analysis of 884 Patients at Facilities Specializing in Pancreatic Surgery.
Nagakawa Y; Sahara Y; Hosokawa Y; Murakami Y; Yamaue H; Satoi S; Unno M; Isaji S; Endo I; Sho M; Fujii T; Takishita C; Hijikata Y; Suzuki S; Kawachi S; Katsumata K; Ohta T; Nagakawa T; Tsuchida A
Ann Surg Oncol; 2019 Jun; 26(6):1629-1636. PubMed ID: 30610555
[TBL] [Abstract][Full Text] [Related]
15. Cost-effectiveness and clinical efficacy of biliary stents in patients undergoing neoadjuvant therapy for pancreatic adenocarcinoma in a randomized controlled trial.
Gardner TB; Spangler CC; Byanova KL; Ripple GH; Rockacy MJ; Levenick JM; Smith KD; Colacchio TA; Barth RJ; Zaki BI; Tsapakos MJ; Gordon SR
Gastrointest Endosc; 2016 Sep; 84(3):460-6. PubMed ID: 26972022
[TBL] [Abstract][Full Text] [Related]
16. Comparing neoadjuvant chemotherapy with or without radiation therapy for pancreatic ductal adenocarcinoma: National Cancer Database cohort analysis.
Oba A; Wu YHA; Colborn KL; Karam SD; Meguid C; Al-Musawi MH; Bao QR; Gleisner AL; Ahrendt S; Schulick RD; Del Chiaro M
Br J Surg; 2022 Apr; 109(5):450-454. PubMed ID: 35136963
[TBL] [Abstract][Full Text] [Related]
17. Effect of preoperative biliary stent on postoperative complications after pancreaticoduodenectomy for cancer: Neoadjuvant versus upfront treatment.
Tamburrino D; Guarneri G; Provinciali L; Riggio V; Pecorelli N; Cinelli L; Partelli S; Crippa S; Falconi M; Balzano G
Surgery; 2022 Dec; 172(6):1807-1815. PubMed ID: 36253311
[TBL] [Abstract][Full Text] [Related]
18. Survival Outcomes Associated With Clinical and Pathological Response Following Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Chemotherapy in Resected Pancreatic Cancer.
Macedo FI; Ryon E; Maithel SK; Lee RM; Kooby DA; Fields RC; Hawkins WG; Williams G; Maduekwe U; Kim HJ; Ahmad SA; Patel SH; Abbott DE; Schwartz P; Weber SM; Scoggins CR; Martin RCG; Dudeja V; Franceschi D; Livingstone AS; Merchant NB
Ann Surg; 2019 Sep; 270(3):400-413. PubMed ID: 31283563
[TBL] [Abstract][Full Text] [Related]
19. Occlusion rate and complications of plastic biliary stent placement in patients undergoing neoadjuvant chemoradiotherapy for pancreatic cancer with malignant biliary obstruction.
Boulay BR; Gardner TB; Gordon SR
J Clin Gastroenterol; 2010 Jul; 44(6):452-5. PubMed ID: 20179612
[TBL] [Abstract][Full Text] [Related]
20. Vasculitis, CA19-9, and Perineural Invasion Differentially Predict Response and Surgical Outcome in Pancreatic Ductal Adenocarcinoma.
Piper M; Ross RB; Hu J; Watanabe S; Knitz M; Mehrotra S; Shulick R; Chiaro MD; Karam SD
Int J Radiat Oncol Biol Phys; 2023 Jul; 116(3):627-639. PubMed ID: 36599398
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
